Grimes & Company’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-9,850
Closed -$153K 244
2019
Q4
$153K Buy
+9,850
New +$153K 0.01% 255